the power of premature publicity

Methylprednisolone in Acute Spinal Cord Injury:
A Tarnished Standard


CONCLUSIONS
It cannot be said at this point that MPR has no
beneficial effects in the treatment of acute spinal cord
injury, but it seems clear that if any benefit exists, it is
probably small and has not been demonstrated by the
NASCIS studies. The publication of the Guidelines19 has
probably eased the pressure on many skeptical clinicians
to continue its routine use in acute spinal cord injury.
However, the issue has emphasized the power of
premature publicity and the hazard of uncritical acceptance
of insufficiently proven therapeutic measures   Journal of neurosurgical anesthesiology.pdf (73.76 KB)


How many chances we going to give that researcher to pull this off again?